Showing 1,241 - 1,260 results of 226,626 for search '(( 10 ((ng decrease) OR (a decrease)) ) OR ( 5 ((ng decrease) OR (a decrease)) ))', query time: 1.94s Refine Results
  1. 1241
  2. 1242
  3. 1243
  4. 1244
  5. 1245
  6. 1246

    L-NAME but not D-NAME decreased iNOS expression of the intestinal mucosa, hepatic bacteria clearance, and IL-1β as well as TNF-α expression of the Kupffer cells in STZ-DM mice. by Shu-Han Lin (4020353)

    Published 2017
    “…STZ-DM mice were fed with an L-NAME (0.5 mg/ml) or D-NAME (0.5 mg/ml, as a control drug) in drinking water for one week. …”
  7. 1247
  8. 1248

    Levosimendan protects human hepatocytes from ischemia-reperfusion injury by Stefanie N. Brunner (4598818)

    Published 2017
    “…After the hypoxic phase, reoxygenation was implemented and cells were treated with different concentrations of levosimendan (10ng/ml, 100ng/ml, 1000ng/ml). The overall metabolic activity of the cells was measured using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), and aspartate aminotransferase (AST) levels were determined in order to quantify hepatic injury. …”
  9. 1249
  10. 1250
  11. 1251

    Cumulative effects and geographic distribution of mCHG-decreasing alleles. by Eriko Sasaki (501178)

    Published 2022
    “…<b>(D)</b> The number of recent transposon insertions [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1010345#pgen.1010345.ref022" target="_blank">22</a>] as a function of <i>NRPE1’</i> genotype and the number of mCHG-decreasing alleles. …”
  12. 1252
  13. 1253
  14. 1254

    Top 10 gene ontologies with the lowest p-value. by Rizka Fatriani (17485787)

    Published 2024
    “…Furthermore, the RMSD was 2.70 Å for EP300 and the native ligand 99E, and the lowest RMSD with the ligand (1R,9S)-5-[(E)-2-(4-Chlorophenyl)vinyl]-11-(5-pyrimidinylcarbonyl)-7,11-diazatricyclo[7.3.1.02,7]trideca-2,4-dien-6-one was 3.33 Å. …”
  15. 1255
  16. 1256

    Lithium Decreases Glial Fibrillary Acidic Protein in a Mouse Model of Alexander Disease by Christine M. LaPash Daniels (796881)

    Published 2015
    “…Here we tested whether lithium treatment would decrease levels of GFAP in a mouse model of Alexander disease. …”
  17. 1257
  18. 1258
  19. 1259

    Binding sensogram (a) showing decrease in frequency of crystal immobilised with 1.5 M short aptamer exposed to different concentrations of heparanase. by Suzanne C. Simmons (319222)

    Published 2013
    “…<p>Higher concentrations of heparanase exhibited a greater decrease in frequency. Binding and regeneration sensogram (b) for addition of 800 nM heparanase to a quartz crystal immobilised with 1.5 M short aptamer. …”
  20. 1260